Pediatrix Medical Intrinsic Stock Value – Zacks Research Boosts Q4 2024 EPS Estimates for Pediatrix Medical Group,

☀️Trending News

Zacks Research has recently increased its Q4 2024 Earnings Per Share (EPS) estimates for Pediatrix Medical ($NYSE:MD) Group, Inc. (PEDIATRIX MEDICAL). PEDIATRIX MEDICAL is a renowned provider of neonatal, maternal-fetal, pediatric, and pediatric cardiac critical care services. The company’s comprehensive medical services include neonatal and pediatric intensive care, maternal-fetal medicine, neonatal and pediatric transport, and other specialized services such as respiratory therapy, respiratory care, and genetic testing. PEDIATRIX MEDICAL is focused on providing the highest quality patient care and service to premature infants, newborns and their families in the United States. Zacks Research’s recent increase in its Q4 2024 EPS estimate for PEDIATRIX MEDICAL is based on several positive factors, such as the company’s strong financial performance in recent quarters and its expanding customer base.

Additionally, the company’s strong focus on innovation and technology has enabled it to provide innovative medical solutions to its customers. This has helped PEDIATRIX MEDICAL to improve its market share in the U.S. healthcare market. With the increasing demand for healthcare services and the company’s strong focus on providing high-quality services, PEDIATRIX MEDICAL is expected to continue its strong financial performance in the quarters ahead.

Earnings

Zacks Research has recently boosted its estimates for Q4 2024 earnings by PEDIATRIX MEDICAL Group, Inc. According to the earnings report of FY2023 Q3 as of September 30, 2021, the company earned a total revenue of 492.95M USD and a net income of 30.8M USD, representing a slight 0.6% increase in total revenue and 0.2% increase in net income in comparison to the year before. Over the last three years, PEDIATRIX MEDICAL’s total revenue has grown from 492.95M USD to 506.61M USD. This is indicative of the company’s steady growth over time and its ability to adapt to the changing economic conditions.

About the Company

Income Snapshot

Below shows the total revenue, net income and net margin for Pediatrix Medical. More…

Cash Flow Snapshot

Below shows the cash from operations, investing and financing for Pediatrix Medical. More…

Balance Sheet Snapshot

Below shows the total assets, liabilities and book value per share for Pediatrix Medical. More…

Key Ratios Snapshot

Some of the financial key ratios for Pediatrix Medical are shown below. More…

Share Price

On Thursday, PEDIATRIX MEDICAL Group, Inc., saw a surge in its stock price after Zacks Investment Research raised the company’s earnings estimates for the fourth quarter of 2024. The stock opened at $9.2 and closed at $9.4, representing a 1.9% increase from its previous closing price of $9.2. This serves as a positive indicator that the company is on track to reach its performance goals. Live Quote…

Analysis – Pediatrix Medical Intrinsic Stock Value

GoodWhale’s analysis of PEDIATRIX MEDICAL‘s fundamentals shows that the fair value of PEDIATRIX MEDICAL shares is around $22.0, calculated by our proprietary Valuation Line. Currently the stock is trading at $9.4, undervalued by 57.3%. We recommend monitoring PEDIATRIX MEDICAL closely to take advantage of the current market conditions. More…

Peers

The company offers its services to medical groups, hospitals, health plans, and other healthcare organizations. Mednax Inc has a network of over 3,000 physicians and over 200 hospitals. The company has its headquarters in Fort Lauderdale, Florida. Radius Residential Care Ltd is a provider of residential care services in the United Kingdom. The company offers its services to people with learning disabilities, mental health problems, and physical disabilities. Radius Residential Care Ltd has a network of over 100 care homes and employs over 2,000 staff. The company has its headquarters in London, England. Hanger Inc is a provider of orthotic and prosthetic services in the United States. The company offers its services to patients, hospitals, and other healthcare organizations. Hanger Inc has a network of over 700 locations and employs over 4,000 people. The company has its headquarters in Austin, Texas. Ambea AB is a provider of healthcare services in Sweden. The company offers its services to people with mental illness, physical disabilities, and substance abuse problems. Ambea AB has a network of over 60 care homes and employs over 5,000 staff. The company has its headquarters in Stockholm, Sweden.

– Radius Residential Care Ltd ($NZSE:RAD)

Radius Residential Care Ltd is a provider of high quality residential aged care services. The company has a market cap of 83.47M as of 2022 and a Return on Equity of 16.16%. Radius Residential Care Ltd operates a network of aged care facilities across Australia and New Zealand. The company is committed to providing quality care for the elderly and to meeting the needs of its residents.

– Hanger Inc ($LTS:0RNX)

Amba AB is a Swedish multinational conglomerate with a focus on healthcare and medical technology. The company has a market cap of 4.8 billion as of 2022 and a return on equity of 9.28%. Amba AB’s core businesses include medical devices, diagnostics, and pharmaceuticals. The company has a strong presence in Europe and North America and is expanding into Asia and the rest of the world.

Summary

Pediatrix Medical Group, Inc. (PEDI) is an attractive investment opportunity according to recent Zacks research. The firm specializes in providing care for newborn and premature infants, as well as pediatric physician services. The research suggests that PEDI is well-positioned for sustained growth in the coming quarters. The company has a proven track record of strong revenue and profit growth, as well as high liquidity.

It also maintains a healthy balance sheet and has experienced a sharp increase in its share price in 2021. PEDI is a solid long-term investment for those looking to gain exposure to the healthcare sector.